Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134967) titled 'A clinical study of marostat peptide combined with levonorgestrel-releasing intrauterine system for the treatment of atypical endometrial hyperplasia or early endometrial adenocarcinoma in overweight/obese patients with the aim of preserving fertility: A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial' on Oct. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Condition:
Atypical endometrial hyperplasia
early-stage endometrioid endometrial carcinoma
overweight ...